Navigation Links
Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
Date:10/22/2007

SWARTZ CREEK, Mich., Oct. 22 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Atheer A. Kaddis has joined the company's executive management team. Dr. Kaddis will serve as Vice President of Managed Markets for the company. He reports directly to Diplomat Specialty Pharmacy's President and CEO, Philip Hagerman.

"The addition of Atheer Kaddis offers Diplomat the Managed Care expertise we need to further develop competitive, cost saving specialty programs making us an attractive choice for health care plans," comments Hagerman. "Atheer's wealth of knowledge in the managed care arena will be invaluable to us as we continue to expand nationally."

Dr. Kaddis stated, "I believe that Diplomat Specialty Pharmacy is a great organization that has made a commitment to help its patients, providers, and customers navigate the complexities of specialty pharmacy in order to provide access to cost-effective, high quality care. I am very excited to be a part of the Diplomat Specialty Pharmacy team."

Before joining Diplomat, Dr. Kaddis worked for Blue Cross Blue Shield of Michigan (BCBSM) as their Director of Pharmacy Services-Clinical. As the Director of Pharmacy Services-Clinical, Dr. Kaddis was responsible for the development and implementation of the specialty pharmacy program, development of the prescription drug formulary, development of clinical pharmacy programs, drug information, provider education, and customer liaison activities. Dr. Kaddis' previous experience also includes the position of Associate Director, Clinical Services at Merck-Medco. Dr. Kaddis is a graduate of the Doctor of Pharmacy program at Wayne State University in Detroit, Michigan.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns

Executive Assistant

Diplomat Specialty Pharmacy

810.720.4452

kkarns@diplomatpharmacy.com


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Charter and Berbee connect Pharmacy Cooperative
2. Germantown drug company hires pharma veteran James Davidson as COO
3. Merge Healthcare hires new VP of finance
4. PDS hires new VP, buys former health club building
5. Siemens health services president calls IT benefits unassailable
6. Wisconsin IT association names Gee president, CEO
7. Merge Healthcare promotes Bowers to president
8. Quintessence Biosciences names new president
9. VanderSanden appointed president of AT&T Wisconsin
10. Merge president steps down in wake of shareholder suits
11. Milwaukees PointOne appoints new president and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):